Current and historical daily PE Ratio for Amphastar Pharmaceuticals Inc (
) from 2014 to May 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Amphastar Pharmaceuticals stock (AMPH) PE ratio as of May 13 2024 is 14.66.
More Details
Amphastar Pharmaceuticals Inc (AMPH) PE Ratio (TTM) Chart
Amphastar Pharmaceuticals Inc (AMPH) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Amphastar Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-14 | 14.7 | 2024-03-08 | 17.7 |
| 2024-05-10 | 14.6 | 2024-03-07 | 18.1 |
| 2024-05-09 | 14.7 | 2024-03-06 | 17.9 |
| 2024-05-08 | 14.6 | 2024-03-05 | 18.3 |
| 2024-05-07 | 14.8 | 2024-03-04 | 18.1 |
| 2024-05-06 | 14.8 | 2024-03-01 | 17.9 |
| 2024-05-03 | 14.7 | 2024-02-29 | 18.1 |
| 2024-05-02 | 14.8 | 2024-02-28 | 21.2 |
| 2024-05-01 | 14.6 | 2024-02-27 | 21.5 |
| 2024-04-30 | 14.3 | 2024-02-26 | 21.4 |
| 2024-04-29 | 14.5 | 2024-02-23 | 20.7 |
| 2024-04-26 | 14.2 | 2024-02-22 | 20.1 |
| 2024-04-25 | 14.1 | 2024-02-21 | 19.9 |
| 2024-04-24 | 14.2 | 2024-02-20 | 20.3 |
| 2024-04-23 | 14.2 | 2024-02-16 | 20.9 |
| 2024-04-22 | 13.9 | 2024-02-15 | 21.5 |
| 2024-04-19 | 13.8 | 2024-02-14 | 21.3 |
| 2024-04-18 | 13.4 | 2024-02-13 | 21.2 |
| 2024-04-17 | 13.9 | 2024-02-12 | 21.7 |
| 2024-04-16 | 14.2 | 2024-02-09 | 21.6 |
| 2024-04-15 | 14.1 | 2024-02-08 | 21.2 |
| 2024-04-12 | 13.7 | 2024-02-07 | 20.5 |
| 2024-04-11 | 13.9 | 2024-02-06 | 20.3 |
| 2024-04-10 | 13.9 | 2024-02-05 | 20.3 |
| 2024-04-09 | 14.2 | 2024-02-02 | 20.5 |
| 2024-04-08 | 14.2 | 2024-02-01 | 20.7 |
| 2024-04-05 | 14.5 | 2024-01-31 | 20.7 |
| 2024-04-04 | 14.4 | 2024-01-30 | 21.3 |
| 2024-04-03 | 14.5 | 2024-01-29 | 21.5 |
| 2024-04-02 | 14.6 | 2024-01-26 | 20.9 |
| 2024-04-01 | 15.0 | 2024-01-25 | 20.6 |
| 2024-03-28 | 15.2 | 2024-01-24 | 21.4 |
| 2024-03-27 | 16.9 | 2024-01-23 | 21.5 |
| 2024-03-26 | 16.8 | 2024-01-22 | 21.7 |
| 2024-03-25 | 16.9 | 2024-01-19 | 21.3 |
| 2024-03-22 | 16.9 | 2024-01-18 | 21.9 |
| 2024-03-21 | 17.3 | 2024-01-17 | 21.8 |
| 2024-03-20 | 17.1 | 2024-01-16 | 21.5 |
| 2024-03-19 | 17.3 | 2024-01-12 | 21.0 |
| 2024-03-18 | 16.6 | 2024-01-11 | 20.9 |
| 2024-03-15 | 16.7 | 2024-01-10 | 21.3 |
| 2024-03-14 | 16.7 | 2024-01-09 | 22.0 |
| 2024-03-13 | 16.9 | 2024-01-08 | 23.0 |
| 2024-03-12 | 17.1 | 2024-01-05 | 24.3 |
| 2024-03-11 | 17.0 | 2024-01-04 | 24.6 |
Amphastar Pharmaceuticals Inc (AMPH) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Amphastar Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US03209R1032
Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers